Joel Tärning

15.5k total citations · 1 hit paper
200 papers, 5.1k citations indexed

About

Joel Tärning is a scholar working on Public Health, Environmental and Occupational Health, Computational Theory and Mathematics and Pharmacology. According to data from OpenAlex, Joel Tärning has authored 200 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 133 papers in Public Health, Environmental and Occupational Health, 51 papers in Computational Theory and Mathematics and 49 papers in Pharmacology. Recurrent topics in Joel Tärning's work include Malaria Research and Control (124 papers), Computational Drug Discovery Methods (51 papers) and Drug Transport and Resistance Mechanisms (36 papers). Joel Tärning is often cited by papers focused on Malaria Research and Control (124 papers), Computational Drug Discovery Methods (51 papers) and Drug Transport and Resistance Mechanisms (36 papers). Joel Tärning collaborates with scholars based in Thailand, United Kingdom and United States. Joel Tärning's co-authors include Nicholas J. White, Niklas Lindegårdh, François Nosten, Nicholas Day, Warunee Hanpithakpong, Rose McGready, Anil Kumar Anal, Muhammad Bilal Sadiq, Richard M. Hoglund and Michael Ashton and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Joel Tärning

190 papers receiving 5.0k citations

Hit Papers

Dihydroartemisinin–piperaquine resistance in Plasmodium f... 2016 2026 2019 2022 2016 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Dihydroartemisinin–piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study
    2016 329 citations Daniel Blessborn, Joel Tärning et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joel Tärning Thailand 38 3.3k 1.1k 923 890 664 200 5.1k
Niklas Lindegårdh Thailand 44 3.6k 1.1× 1.3k 1.1× 1.2k 1.3× 653 0.7× 672 1.0× 117 5.0k
Elizabeth A. Ashley United Kingdom 48 5.9k 1.8× 1.6k 1.4× 1.0k 1.1× 920 1.0× 985 1.5× 178 8.0k
Polrat Wilairatana Thailand 45 3.7k 1.1× 757 0.7× 1.1k 1.2× 655 0.7× 351 0.5× 319 7.2k
Kasia Stepniewska United Kingdom 49 5.1k 1.6× 1.2k 1.1× 896 1.0× 1.4k 1.6× 686 1.0× 126 8.3k
Sasithon Pukrittayakamee Thailand 49 5.8k 1.8× 892 0.8× 810 0.9× 1.2k 1.3× 485 0.7× 143 7.4k
Michèle van Vugt Netherlands 40 3.7k 1.1× 766 0.7× 783 0.8× 1.5k 1.7× 652 1.0× 144 5.7k
Pratap Singhasivanon Thailand 47 5.2k 1.6× 906 0.8× 794 0.9× 1.1k 1.3× 1.2k 1.7× 199 7.4k
Juntra Karbwang Thailand 38 3.0k 0.9× 480 0.4× 973 1.1× 424 0.5× 367 0.6× 165 4.7k
Pascal Ringwald Switzerland 45 6.3k 1.9× 2.0k 1.8× 1.4k 1.5× 689 0.8× 304 0.5× 182 7.0k
Steven R. Meshnick United States 40 3.6k 1.1× 632 0.6× 362 0.4× 1.0k 1.1× 681 1.0× 136 5.5k

Countries citing papers authored by Joel Tärning

Since Specialization
Citations

This map shows the geographic impact of Joel Tärning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Tärning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Tärning more than expected).

Fields of papers citing papers by Joel Tärning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel Tärning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Tärning. The network helps show where Joel Tärning may publish in the future.

Co-authorship network of co-authors of Joel Tärning

This figure shows the co-authorship network connecting the top 25 collaborators of Joel Tärning. A scholar is included among the top collaborators of Joel Tärning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel Tärning. Joel Tärning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Popruk, Supaluk, Jumreang Tummatorn, Sumate Ampawong, et al.. (2024). Inhibition of Giardia duodenalis by isocryptolepine -triazole adducts and derivatives. International Journal for Parasitology Drugs and Drug Resistance. 26. 100561–100561. 2 indexed citations
2.
Vanachayangkul, Pattaraporn, Rawiwan Im‐Erbsin, Anchalee Tungtaeng, et al.. (2024). Safety, pharmacokinetics, and potential neurological interactions of ivermectin, tafenoquine, and chloroquine in Rhesus macaques. Antimicrobial Agents and Chemotherapy. 68(6). e0018124–e0018124. 1 indexed citations
3.
Tärning, Joel, et al.. (2024). Use of population pharmacokinetic‐pharmacodynamic modelling to inform antimalarial dose optimization in infants. British Journal of Clinical Pharmacology. 91(4). 968–980. 1 indexed citations
4.
Ding, Junjie, Richard M. Hoglund, Harry Tagbor, et al.. (2024). Population pharmacokinetics of amodiaquine and piperaquine in African pregnant women with uncomplicated Plasmodium falciparum infections. CPT Pharmacometrics & Systems Pharmacology. 13(11). 1893–1903. 2 indexed citations
5.
Cruz, Cintia, Verena I. Carrara, James A Watson, et al.. (2024). Comparison of WHO versus national COVID-19 therapeutic guidelines across the world: not exactly a perfect match. BMJ Global Health. 9(4). e014188–e014188. 5 indexed citations
6.
Wattanakul, Thanaporn, Mary Ellen Gilder, Rose McGready, et al.. (2024). Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants. Nature Communications. 15(1). 3851–3851. 5 indexed citations
7.
Chan, Xin Hui S, Md Zakiul Hassan, Tara Hurst, et al.. (2024). Nipah Virus Therapeutics: A Systematic Review to Support Prioritisation for Clinical Trials. medRxiv. 2 indexed citations
8.
Ding, Junjie, Richard M. Hoglund, & Joel Tärning. (2024). Medication adherence framework: A population‐based pharmacokinetic approach and its application in antimalarial treatment assessments. CPT Pharmacometrics & Systems Pharmacology. 13(5). 795–811. 1 indexed citations
9.
Tärning, Joel, Aurélie Fricot, Pablo Gamallo, et al.. (2023). Safe drugs with high potential to block malaria transmission revealed by a spleen-mimetic screening. Nature Communications. 14(1). 1951–1951. 7 indexed citations
10.
Cavany, Sean, Cherry Lim, Joel Tärning, et al.. (2023). The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance. Nature Communications. 14(1). 6153–6153. 22 indexed citations
11.
Wattanakul, Thanaporn, Palang Chotsiri, Ivan Scandale, Richard M. Hoglund, & Joel Tärning. (2022). A pharmacometric approach to evaluate drugs for potential repurposing as COVID-19 therapeutics. Expert Review of Clinical Pharmacology. 15(8). 945–958. 4 indexed citations
12.
Hoglund, Richard M., et al.. (2022). Drug development for the treatment of onchocerciasis: Population pharmacokinetic and adverse events modeling of emodepside. PLoS neglected tropical diseases. 16(3). e0010219–e0010219. 5 indexed citations
13.
Chu, Cindy S., James A Watson, Aung Pyae Phyo, et al.. (2021). Determinants of Primaquine and Carboxyprimaquine Exposures in Children and Adults with Plasmodium vivax Malaria. Antimicrobial Agents and Chemotherapy. 65(11). e0130221–e0130221. 6 indexed citations
14.
Sjögren, Erik, Joel Tärning, Karen I. Barnes, & E. Niclas Jonsson. (2021). A Physiologically-Based Pharmacokinetic Framework for Prediction of Drug Exposure in Malnourished Children. Pharmaceutics. 13(2). 204–204. 7 indexed citations
15.
Pan–ngum, Wirichada, et al.. (2020). Assessment of the amino acid profile in Thai patients with type 2 diabetes mellitus using liquid chromatography-mass spectrometry. International Health. 13(4). 367–373. 4 indexed citations
16.
Watson, James A, et al.. (2019). Pharmacokinetic-Pharmacodynamic Assessment of the Hepatic and Bone Marrow Toxicities of the New Trypanoside Fexinidazole. Antimicrobial Agents and Chemotherapy. 63(4). 19 indexed citations
17.
Hoglund, Richard M., et al.. (2019). DRUG DEVELOPMENT FOR THE TREATMENT AND CONTROL OF ONCHOCERCIASIS: A POPULATION PHARMACOKINETIC ANALYSIS OF EMODEPSIDE (BAY 44-4400) IN HEALTHY VOLUNTEERS. American Journal of Tropical Medicine and Hygiene. 101. 391–392. 1 indexed citations
18.
Meister, Isabel, Fiona Vanobberghen, Melissa A. Penny, et al.. (2019). Pooled Population Pharmacokinetic Analysis of Tribendimidine for the Treatment of Opisthorchis viverrini Infections. Antimicrobial Agents and Chemotherapy. 63(4). 6 indexed citations
19.
Scarsi, Kimberly K., Fatai A. Fehintola, Qing Ma, et al.. (2014). Disposition of amodiaquine and desethylamodiaquine in HIV-infected Nigerian subjects on nevirapine-containing antiretroviral therapy. Journal of Antimicrobial Chemotherapy. 69(5). 1370–1376. 15 indexed citations
20.
Saralamba, Sompob, Wirichada Pan–ngum, Richard J. Maude, et al.. (2010). Intrahost modeling of artemisinin resistance in Plasmodium falciparum. Proceedings of the National Academy of Sciences. 108(1). 397–402. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Niklas Lindegårdh Breakdown of academic impact, for papers by Elizabeth A. Ashley Breakdown of academic impact, for papers by Polrat Wilairatana Breakdown of academic impact, for papers by Kasia Stepniewska Breakdown of academic impact, for papers by Sasithon Pukrittayakamee Breakdown of academic impact, for papers by Michèle van Vugt Breakdown of academic impact, for papers by Pratap Singhasivanon Breakdown of academic impact, for papers by Juntra Karbwang Breakdown of academic impact, for papers by Pascal Ringwald Breakdown of academic impact, for papers by Steven R. Meshnick
Rankless by CCL
2026